Proficio Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $870K | Sell |
1,955
-124
| -6% | -$55.2K | 0.05% | 171 |
|
2025
Q1 | $1.01M | Buy |
2,079
+1,101
| +113% | +$534K | 0.08% | 129 |
|
2024
Q4 | $394K | Buy |
978
+311
| +47% | +$125K | 0.03% | 226 |
|
2024
Q3 | $310K | Sell |
667
-179
| -21% | -$83.2K | 0.03% | 213 |
|
2024
Q2 | $397K | Buy |
846
+23
| +3% | +$10.8K | 0.04% | 198 |
|
2024
Q1 | $344K | Buy |
823
+34
| +4% | +$14.2K | 0.04% | 222 |
|
2023
Q4 | $321K | Sell |
789
-4
| -0.5% | -$1.63K | 0.04% | 213 |
|
2023
Q3 | $276K | Buy |
793
+73
| +10% | +$25.4K | 0.04% | 231 |
|
2023
Q2 | $253K | Buy |
720
+32
| +5% | +$11.3K | 0.03% | 243 |
|
2023
Q1 | $217K | Buy |
+688
| New | +$217K | 0.03% | 265 |
|
2020
Q4 | – | Sell |
-757
| Closed | -$206K | – | 197 |
|
2020
Q3 | $206K | Buy |
757
+22
| +3% | +$5.99K | 0.04% | 163 |
|
2020
Q2 | $213K | Buy |
+735
| New | +$213K | 0.04% | 157 |
|
2019
Q3 | – | Sell |
-333
| Closed | -$61K | – | 1507 |
|
2019
Q2 | $61K | Buy |
333
+14
| +4% | +$2.57K | 0.02% | 317 |
|
2019
Q1 | $59K | Buy |
319
+66
| +26% | +$12.2K | 0.02% | 298 |
|
2018
Q4 | $42K | Sell |
253
-5
| -2% | -$830 | 0.02% | 341 |
|
2018
Q3 | $50K | Buy |
258
+8
| +3% | +$1.55K | 0.02% | 353 |
|
2018
Q2 | $42K | Buy |
250
+10
| +4% | +$1.68K | 0.02% | 401 |
|
2018
Q1 | $39K | Sell |
240
-8
| -3% | -$1.3K | 0.01% | 416 |
|
2017
Q4 | $37K | Sell |
248
-52
| -17% | -$7.76K | 0.01% | 422 |
|
2017
Q3 | $46K | Buy |
300
+19
| +7% | +$2.91K | 0.02% | 399 |
|
2017
Q2 | $44K | Buy |
281
+31
| +12% | +$4.85K | 0.02% | 410 |
|
2017
Q1 | $29K | Buy |
250
+172
| +221% | +$20K | 0.01% | 520 |
|
2016
Q4 | $6K | Buy |
78
+7
| +10% | +$538 | ﹤0.01% | 726 |
|
2016
Q3 | $6K | Buy |
71
+13
| +22% | +$1.1K | ﹤0.01% | 689 |
|
2016
Q2 | $6K | Buy |
58
+54
| +1,350% | +$5.59K | ﹤0.01% | 671 |
|
2016
Q1 | $0 | Sell |
4
-41
| -91% | – | ﹤0.01% | 1179 |
|
2015
Q4 | $6K | Buy |
+45
| New | +$6K | 0.01% | 396 |
|